Relay Therapeutics Inc Logo

Relay Therapeutics Inc (RLAY): Eigentümerstruktur

Takani Score ?
29.4

Preis (11.09.2026)52W Hoch52W Tief
18,87 US Dollar21,27 US Dollar3,885 US Dollar
Analysten KonsensBuyOutperformHoldUnderperformSell
27,077 US Dollar65200
Externe Analystenschätzungen (Quelle: EODHD) – keine Anlageempfehlung von Takani.
#SharesShort [%]Short Ratio
219.141.63123,1418,99

Eigentümerstruktur

Analyse der Aktionärsstruktur und institutionellen Investoren

Unternehmensdaten

Grundlegende Informationen

Grunddaten

Name Relay Therapeutics Inc
Mitarbeiter 202
Handelsplatz NASDAQ
Ticker Symbol RLAY
IPO Datum 2020-07-16
Adresse 60 Hampshire Street, Cambridge, MA, United States, 02139

Unternehmensführung

RangNamePosition
1Dr. Sanjiv K. Patel M.A., M.B.A., M.D., MBBSCEO, President & Director
2Dr. Mark Murcko Ph.D.Founder & Independent Director
3Mr. Thomas CatinazzoChief Financial Officer
4Mr. Peter RahmerChief Corporate Development Officer
5Dr. Donald A. Bergstrom M.D., Ph.D.President of Research & Development
6Ms. Dorothee Kern Ph.D.Founder
7Dr. David Elliot Shaw Ph.D.Founder
8Dr. Matthew P. Jacobson Ph.D.Founder
9Mr. Jim Watters Ph.D.Chief Scientific Officer
10Ms. Soo-Yeun Lim J.D.Senior VP & General Counsel

Aktionärsverteilung

Aufteilung der Investoren

Größte Investoren

RangInhaberAnteileWert
1SB INVESTMENT ADVISERS (UK) LTD12,73%0,53 Mrd. USD
2COMMODORE CAPITAL LP7,76%0,32 Mrd. USD
3Casdin Capital, LLC7,32%0,30 Mrd. USD
4Perceptive Advisors LLC6,44%0,27 Mrd. USD
5BlackRock Inc5,92%0,25 Mrd. USD
6Bellevue Group AG3,56%0,15 Mrd. USD
7Vanguard Capital Management, LLC3,37%0,14 Mrd. USD
8Nextech Invest, Ltd.3,09%0,13 Mrd. USD
9State Street Corp2,84%0,12 Mrd. USD
10TCG Crossover Management, LLC1,95%0,08 Mrd. USD
11FMR Inc1,69%0,07 Mrd. USD
12Geode Capital Management, LLC1,60%0,07 Mrd. USD
13Westfield Capital Management Company, L.P.1,53%0,06 Mrd. USD
14Kynam Capital Management, LP1,51%0,06 Mrd. USD
15Dimensional Fund Advisors, Inc.1,43%0,06 Mrd. USD
16Balyasny Asset Management LLC1,39%0,06 Mrd. USD
17Spruce Street Capital LP1,36%0,06 Mrd. USD
18The Goldman Sachs Group Inc1,16%0,05 Mrd. USD
19MPM Oncology Impact Management LP1,10%0,05 Mrd. USD
20Pictet Asset Manangement SA0,95%0,04 Mrd. USD